COVID 19

April 20, 2021
April 20, 2021

EU agency says benefits of Johnson & Johnson vaccine outweigh blood clot risk

Experts at the agency that regulates drugs for the European Union said Tuesday that they found a “possible link” between the Johnson & Johnson COVID-19 vaccine and very rare blood clots after a small number of cases were reported in the United States, but they confirmed the vaccine’s benefits still outweighed the very small risks of recipients developing the unusual clots.
You did not use the site, Click here to remain logged. Timeout: 60 second